Application of the Sleep C.A.L.M. Tool for Assessing Nocturia in a Large Nationally Representative Cohort
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: Nocturia significantly impacts patients’ quality of life but remains insufficiently evaluated and treated. The “Sleep C.A.L.M.” system categorizes the factors thought to collectively reflect most underlying causes of nocturia (Sleep disorders, Comorbidities, Actions [i.e., modifiable patient behaviors such as excess fluid intake], Lower urinary tract dysfunction, and Medications). The purpose of this study was to assess the association of nocturia with the Sleep C.A.L.M. categories using a nationally representative dataset. Methods: Retrospective analysis of the National Health and Nutrition Examination Survey from 2013/14–2017/18 cycles was conducted. Pertinent questionnaire, laboratory, dietary, and physical examination data were used to ascertain the presence of Sleep C.A.L.M. categories in adults ≥20 years of age. Nocturia was defined as ≥2 nighttime voids. Results: A total of 12,274 included subjects were included (51.6% female; median age, 49.0 years [interquartile range, 34.0–62.0 years]; 27.6% nocturia). Among subjects with nocturia, the prevalence of 0, ≥1, and ≥2 Sleep C.A.L.M. categories was 3.5% (95% confidence interval [CI], 2.8%–4.4%), 96.5% (95% CI, 95.6%–97.2%), and 81.2% (95% CI, 78.9%–83.3%), respectively. Compared to those with 0–1 Sleep C.A.L.M. categories, the adjusted odds of nocturia in subjects with 2, 3, and 4–5 Sleep C. A.L.M. categories were 1.77 (95% CI, 1.43–2.21), 2.33 (1.89–2.87), and 3.49 (2.81–4.35), respectively (P<0.001). Similar trends were observed for most age and sex subgroups. When assessed individually, each of the 5 Sleep C.A.L.M. categories were independently associated with greater odds of nocturia, which likewise persisted across multiple age and sex subgroups. Conclusions: Sleep C.A.L.M. burden is associated with increased odds of nocturia in a dose-dependent fashion, and potentially a relevant means by which to organize the underlying etiologies for nocturia among community-dwelling adults.
Abstract
Purpose: Nocturia significantly impacts patients’ quality of life but remains insufficiently evaluated and treated. The “Sleep C.A.L.M.” system categorizes the factors thought to collectively reflect most underlying causes of nocturia (Sleep disorders, Comorbidities, Actions [i.e., modifiable patient behaviors such as excess fluid intake], Lower urinary tract dysfunction, and Medications). The purpose of this study was to assess the association of nocturia with the Sleep C.A.L.M. categories using a nationally representative dataset. Methods: Retrospective analysis of the National Health and Nutrition Examination Survey from 2013/14–2017/18 cycles was conducted. Pertinent questionnaire, laboratory, dietary, and physical examination data were used to ascertain the presence of Sleep C.A.L.M. categories in adults ≥20 years of age. Nocturia was defined as ≥2 nighttime voids. Results: A total of 12,274 included subjects were included (51.6% female; median age, 49.0 years [interquartile range, 34.0–62.0 years]; 27.6% nocturia). Among subjects with nocturia, the prevalence of 0, ≥1, and ≥2 Sleep C.A.L.M. categories was 3.5% (95% confidence interval [CI], 2.8%–4.4%), 96.5% (95% CI, 95.6%–97.2%), and 81.2% (95% CI, 78.9%–83.3%), respectively. Compared to those with 0–1 Sleep C.A.L.M. categories, the adjusted odds of nocturia in subjects with 2, 3, and 4–5 Sleep C. A.L.M. categories were 1.77 (95% CI, 1.43–2.21), 2.33 (1.89–2.87), and 3.49 (2.81–4.35), respectively (P<0.001). Similar trends were observed for most age and sex subgroups. When assessed individually, each of the 5 Sleep C.A.L.M. categories were independently associated with greater odds of nocturia, which likewise persisted across multiple age and sex subgroups. Conclusions: Sleep C.A.L.M. burden is associated with increased odds of nocturia in a dose-dependent fashion, and potentially a relevant means by which to organize the underlying etiologies for nocturia among community-dwelling adults.
참고문헌 (21)
- van Kerrebroeck P, "The standardisation of terminology in nocturia : report from the standardisation sub-committee of the International Continence Society", Neurourol Urodyn, 21, pp.179~183 (2002)
- Hashim H, "International Continence Society(ICS)report on the terminology for nocturia and nocturnal lower urinary tract function", Neurourol Urodyn, 38, pp.499~508 (2019)
- Akhavizadegan H, "A comprehensive review of adult enuresis", Can Urol Assoc J, 13, pp.282~287 (2019)
- Oelke M, "Nocturia is often inadequately assessed, diagnosed and treated by physicians : results of an observational, real-life practice database containing 8659 European and US-American patients", Int J Clin Pract, 70, pp.940~949 (2016)
- Monaghan TF, "Sleep Disorders, Comorbidities, Actions, Lower Urinary Tract Dysfunction, and Medications("Sleep C. A. L. M. ")in the evaluation and management of nocturia : a simple approach to a complex diagnosis", Neurourol Urodyn, 42, pp.562~572 (2023)
- Everaert K, "International continence society consensus on the diagnosis and treatment of nocturia", Neurourol Urodyn, 38, pp.478~498 (2019)
- Bosch JL, "The prevalence and causes of nocturia", J Urol, 189(1 Suppl), pp.S86~S92 (2013)
- Bliwise DL, "Cataloging nocturia(circa 2014)", Sleep, 37, pp.631~633 (2014)
- Araujo AB, "Sleep related problems and urological symptoms : testing the hypothesis of bidirectionality in a longitudinal, population based study", Urol, 191, pp.100~106 (2014)
- Weiss JP, "Nocturia: “do the math.”", J Urol, 175(3 Pt 2), pp.S16~S18 (2006)
- Witthaus MW, "Bladder oxidative stress in sleep apnea contributes to detrusor instability and nocturia", J Urol, 193, pp.1692~1699 (2015)
- Umlauf MG, "Obstructive sleep apnea, Nocturia and Polyuria in older adults", Sleep, 27, pp.139~144 (2004)
- Victor RG, "Nocturia as an unrecognized symptom of uncontrolled hypertension in black men aged 35 to 49 years", J Am Heart Assoc, 8, pp.e010794~ (2019)
- Monaghan TF, "Nocturia: a marker of furosemide treatment response? An exploratory study", BJU Int, 125, pp.636~637 (2020)
- Noh JW, "Association between lower urinary tract symptoms and cigarette smoking or alcohol drinking", Transl Androl Urol, 9, pp.312~321 (2020)
- Moon S, "The association between obesity and the Nocturia in the U. S. population", Int Neurourol J, 23, pp.169~176 (2019)
- Tani M, "Guidance on water intake effectively improves urinary frequency in patients with Nocturia", Int J Urol, 21, pp.595~600 (2014)
- Matsuo T, "Effect of salt intake reduction on nocturia in patients with excessive salt intake", Neurourol Urodyn, 38, pp.927~933 (2019)
- Alwis US, "Impact of food and drinks on urine production : a systematic review", Int J Clin Pract, 74, pp.e13539~ (2020)
- Bradley CS, "Evidence of the impact of diet, fluid intake, caffeine, alcohol and tobacco on lower urinary tract symptoms : a systematic review", J Urol, 198, pp.1010~1020 (2017)
- Weiss JP, "Nocturia : focus on etiology and consequences", Rev Urol, 14, pp.48~55 (2012)